Erickson Gayn Reports Common Stock Transaction at Aehr Test
Erickson Gayn, President and CEO of Aehr Test Systems, reports a transaction of 851 shares of common stock, reflecting ongoing insider activity.
Kurtz George Reports Multiple Stock Transactions Involving CrowdStrike
Kurtz George discloses multiple stock transactions involving CrowdStrike Holdings, impacting investor sentiment and market dynamics in the software industry.
Fivespan Partners Reports Major Stock Purchases by Haggart
Fivespan Partners, LP discloses significant stock purchases by Dylan G. Haggart, indicating strong confidence in Stride, Inc. and the educational services sector.
Fivespan Partners, LP Reports Ownership Changes in SEC Filing
Fivespan Partners, LP reports ownership changes involving Dylan G. Haggart in a recent SEC filing, highlighting its investment management focus.
Scholar Rock reports significant insider stock purchases
Scholar Rock Holding Corp reports notable stock transactions by key stakeholders, indicating confidence in the company's future and the biological products sector.
Studio City International updates ownership filings amid changes
Studio City International Holdings Ltd updates ownership filings, reflecting significant transactions by key stakeholders in the hospitality sector.
Engineer Adil Reports Stock Transaction at Aehr Test Systems
Engineer Adil, COO of Aehr Test Systems, reports a transaction involving 202 shares of common stock, reflecting ongoing management activity.
John C. Ivascu Sells 4,800 Shares of Forum Energy Technologies
John C. Ivascu, EVP of Forum Energy Technologies, sells 4,800 shares under a Rule 10b5-1 Plan, leaving him with 75,512 shares.
ADAR1 Capital Management Increases Stake in NextCure, Inc.
ADAR1 Capital Management boosts its stake in NextCure, reflecting confidence in the pharmaceutical sector and the company's prospects.
Yuhjtman Omer files Form 3 as VP Finance at Box Inc.
Yuhjtman Omer files Form 3, confirming his role as VP Finance at Box Inc., emphasizing leadership in the prepackaged software industry.
Basswood Opportunity Partners files to sell shares of Dime Bank
Basswood Opportunity Partners, L.P. files to sell 14,294 shares of Dime Community Bancshares, signaling strategic investment adjustments.
Gibbs David W files Form 3, reveals ownership in Amgen
David W. Gibbs files a Form 3, disclosing his ownership in Amgen Inc., reflecting compliance with SEC regulations and ongoing activity in the biological products sector.
Basswood Financial Fund Files to Sell Shares of Dime Bancshares
Basswood Financial Long Only Fund, L.P. files to sell shares of Dime Community Bancshares, indicating strategic moves in the national commercial banking sector.
JCP Investment Management Restructures Ownership in Red Robin
JCP Investment Management announces changes in ownership and board resignations at Red Robin Gourmet Burgers, signaling a strategic shift.
Basswood Financial Fund to Sell Shares of Dime Community Bancshares
Basswood Financial Fund, Ltd. plans to sell 267 shares of Dime Community Bancshares, Inc., signaling a strategic shift in its investment approach.
Basswood Financial Fund to Sell Shares of Dime Community Bancshares
Basswood Financial Fund, L.P. files to sell shares of Dime Community Bancshares, signaling ongoing activity in the national commercial banking sector.
Basswood Capital Management sells shares in Dime Community Bancshares
Basswood Capital Management sold 25,871 shares in Dime Community Bancshares, reflecting strategic investment moves in the banking sector.
Sinensky Transfers 1 Million Shares to Spouse in SEC Filing
Michael Sinensky reports a transfer of 1 million shares of Powerus Corp to his spouse, reflecting personal and investment strategies.
Basswood Financial Long Only Fund Reports Multiple Stock Sales
Basswood Financial Long Only Fund, L.P. reports multiple stock sales, signaling changes in ownership dynamics that may impact the banking sector.
Radiopharm Theranostics CMO Acquires Significant Stock Options
Radiopharm Theranostics Ltd's CMO Dimitris Voliotis acquires substantial stock options, signaling commitment to growth in the pharmaceutical preparations sector.